Tivic Health Systems 주식 (NASDAQ: TIVC)

에 대한 최신 뉴스 Tivic Health Systems (NASDAQ:TIVC) 주식

Tivic Health Systems

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

KB Home

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

CTRM

EPAC

LUNR

TIVC

월요일(24일) 아침 미국 지수 선물이 상승하고 있는 가운데, 오늘 투자자들의 주목을 받을 수 있는 주식들은 다음과 같다. KB홈, 티빅 헬스, 인튜이티브 머신스, 캐스터 마리타임 및 에너팩 툴

월요일 주목해야 할 주식: KB홈, 티빅 헬스, 인튜이티브 머신스, 캐스터 마리타임 및 에너팩 툴

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems Inc

Keybanc analyst Brett Fishbin maintains Alcon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALC#NYSE">ALC</a>) with a Overweight and raises the price target from $108 to $112.

Price Target

Analyst Ratings

Keybanc Maintains Overweight on Alcon, Raises Price Target to $112

Despite the recent surge to record highs, gold prices might be on the brink of a significant downturn, warn analysts.
What Happened:  Jon Mills, a Morningstar analyst, anticipates a potential 38% tumble to $1,820 an ounce in the next five years, reported <a href="https://www.businessinsider.com/gold-price-prediction-bullion-supply-demand-recession-morningstar-outlook-2025-3">Business Insider</a>. &#8220;I think you have to be careful not to project current spot prices unto eternity or over the long term,&#8221; predicted Mills.
Geopolitical uncertainty, a challenging U.S. economic outlook, and higher inflation expectations have driven gold prices to new heights. Investors have sought solace in safe-haven assets like gold amid these conditions. 
However, Mills identifies three primary factors that could trigger a downward shift in gold prices. Firstly, he expects the market supply of gold to increase, spurred by high gold prices that encourage more mining and recycling. According to the World Gold Council&#8217;s data, the above-ground gold stock has increased by 9% over the past five years, suggesting that gold mining has grown more profitable.
Secondly, Mills foresees a drop in gold demand. Despite recent interest from central banks and investors, a World Gold Council survey shows that 71% of central banks anticipate their gold holdings to either remain constant or decrease in the upcoming year.
Lastly, Mills highlights indications that the gold industry is approaching a peak, as evidenced by the surge in M&amp;A activity and the growth of gold-based funds, both historical indicators of a market peak.
See Also: <a href="https://benzinga.com/25/03/44557947/doge-blowback-aside-elon-musk-considers-tesla-a-solid-opportunity" target="_blank" rel="noreferrer noopener">DOGE Blowback Aside, Elon Musk Thinks Tesla Stock Is Going To Do Fine: &#8216;It&#8217;s A Buying Opportunity&#8217; </a>
 Why It Matters: The recent surge in gold prices has been driven by escalating trade tensions and uncertainty surrounding U.S. tariff policies, including President Donald Trump&#8216;s proposed 25% tariffs on imported cars and auto parts and a new round of reciprocal tariffs <a href="https://www.benzinga.com/25/03/44559190/gold-surges-past-3100-as-tariff-uncertainty-sets-the-silver-ratio-trade">set to take effect </a>on April 2. 
Contrary to Mills&#8217; predictions, other Wall Street forecasters like Bank of America and Goldman Sachs anticipate a continued rise in gold prices in the short term.
Renowned economist Peter Schiff attributes the record-high <a href="https://www.benzinga.com/25/03/44512448/as-gold-hits-record-high-peter-schiff-points-to-dollar-distrust-and-inflation-gold-is-not-rising-due-to-uncertain">gold prices</a> to declining trust in the U.S. dollar and the certainty of inflation exceeding 2%. 
However, the potential increase in gold supply and decrease in demand, as predicted by Mills, could lead to a significant drop in gold prices&nbsp;over the next five years. KCM Trade chief market analyst Tim Waterer echoed a similar sentiment and stated, "If the tariff announcements this week are not as severe as feared, then the gold price could start to backtrack as profit-taking from the highs may be triggered."
<ul>
<li>Read Next:&nbsp;<a href="https://www.benzinga.com/25/03/44556893/loar-holdings-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Loar Holdings Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Commodities

38% Plunge In Gold Prices Over The Next 5 Years, Predicts Analyst: 'Be Careful Not To Project Current Spot Prices Unto Eternity'

Guidance

BIAF

BIAFW

BioAffinity Technologies Sees FY25 Revenue $6M-$8M.

Offerings

PLRZ

Polyrizon Announces $17M Private Placement At $0.48/Unit

BioAFfinity Technologies FY24 EPS (0.75) Up From ($0.91) YoY; Revenue $9.4 million Up From $2.5 Million YoY

Jefferies analyst Brent Thill maintains Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) with a Buy and lowers the price target from $800 to $735.

INTU

Jefferies Maintains Buy on Intuit, Lowers Price Target to $735

m-FINANCE And CBCX Markets Partner To Enhance Liquidity Network

Jefferies analyst Brent Thill maintains IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) with a Hold and lowers the price target from $270 to $265.

Jefferies Maintains Hold on IBM, Lowers Price Target to $265

Keybanc analyst Upal Rana maintains Kilroy Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRC#NYSE">KRC</a>) with a Overweight and lowers the price target from $45 to $41.

Keybanc Maintains Overweight on Kilroy Realty, Lowers Price Target to $41

WIIM

MTEK

Maris-Tech shares are trading lower. The company reported FY24 financial results.

Shares of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) settled lower <a href="https://www.benzinga.com/media/25/03/44509405/after-siri-leadership-change-apple-makes-another-major-executive-move-in-retail-report">after Friday's session</a>.
Apple is reportedly making a change to its leadership structure by promoting Vanessa Trigub, signaling long-term succession planning for Senior Vice President Deirdre O&#8217;Brien. The company has decided to introduce a new position — vice president of stores and retail operations — and name Trigub to the role, according to a report by Bloomberg, citing people with knowledge of the matter.
Trigub, who has been with Apple since 2007 and currently oversees the retail operations in the Americas West region, will now manage global retail store operations and report directly to O&#8217;Brien.
With the recent buzz around Apple, some investors may be eyeing potential gains from the company's dividends too. As of now, Apple offers an annual dividend yield of 0.46%, which is a quarterly dividend amount of $0.25 per share.
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $1,307,400 or around 6,000 shares. For a more modest $100 per month or $1,200 per year, you would need $261,480 or around 1,200 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($1.00 in this case). So, $6,000 / $1.00 = 6,000 ($500 per month), and $1,200 / $1.00 = 1,200 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
AAPL Price Action: Shares of Apple fell 2.7% to close at $217.90 on Friday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44534977/jim-cramer-healthpeak-properties-is-a-reasonable-reit-recommends-buying-this-health-care-stock">Jim Cramer: Healthpeak Properties Is A &#8216;Reasonable&#8217; REIT, Recommends Buying This Health Care Stock</a></li>
</ul>
Image via Shutterstock

Long Ideas

AAPL

How To Earn $500 A Month From Apple Stock

APRE

Aprea Therapeutics shares are trading higher after the company announced it has commenced the dosing of patients with HPV+ head and neck squamous cell carcinoma in its ongoing ACESOT-1051 trial.

"AI Writing Companion" Marks Industry-First Integration of AI Technology and Traditional Composition Materials Projected to Generate Over 5 million USD in Revenue in 2025

NAMI

NamiBox And Tencent Cloud Announce Partner With Sichuan Education Press To Launch AI-Powered Writing Solution

Every market crash feels like a crisis, but what if it's your greatest wealth-building opportunity? History has proven it repeatedly, yet fear keeps many investors from seizing the moment. The opportunity lies not in predicting crashes but in courageously navigating the storm.
<h3 class="wp-block-heading">Historical perspective: Resilience wins</h3>
History makes one thing clear: you shouldn't go rogue, but you should remain resilient. The following chart shows the market's trajectory over the past 120 years.
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="624" height="348" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31104028/Article-31-120-years.jpg" alt="" class="wp-image-9276" style="width:908px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31104028/Article-31-120-years.jpg 624w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31104028/Article-31-120-years-300x167.jpg 300w" sizes="(max-width: 624px) 100vw, 624px" /></figure>
The vertical gray lines represent recessionary periods, with the three most recent being the dot-com bust (2001), the financial crisis meltdown (2008), and the COVID-19 pandemic (2020).
Take note: through all the economic setbacks, wars, and dozens of recessions, the market's trend line over the 120 years is upward. If you believe, as I do, that America's economy and the global markets will continue upward over the long term, then in the short term, stay the course.
Imagine flipping a coin where three out of four times, you win. That's how often the stock market has delivered positive annual returns over the past 45 years. During downturns, many ask, "Will the market recover? (Spoiler: It always has.) The better question to ask yourself is: "Will I still be in the game as the market rebounds?"
<h3 class="wp-block-heading">Market volatility reality check</h3>
But know this: it won't be a smooth ride. Over those 45 years, the market had an intra-year average decline of 14.1%. This means that even in the 34 calendar years with positive returns, significant declines occurred at some point during the year.
Think back to 2020. As the COVID-19 pandemic triggered a shocking 34% market free-fall in just weeks, fear and uncertainty dominated investor sentiment. Yet those who remained disciplined and stayed invested not only weathered the storm but also enjoyed the subsequent surge, with the market closing up 16% for the year.
In stark contrast, those who panicked and sold near the bottom locked in their losses, missing one of the most remarkable market rebounds in modern history.
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="768" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31104148/Article-31-Intra-Year-Declines-1024x768.png" alt="" class="wp-image-9277" style="width:841px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31104148/Article-31-Intra-Year-Declines-1024x768.png 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31104148/Article-31-Intra-Year-Declines-300x225.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31104148/Article-31-Intra-Year-Declines-768x576.png 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31104148/Article-31-Intra-Year-Declines.png 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The odds are on your side for being invested over the long term with a healthy dose of stocks. Short-term volatility, however, makes timing the market a loser's game. Stick to your long-term plan. Stay the course.
<h3 class="wp-block-heading">The Entrepreneur&#8217;s mindset: Opportunity in uncertainty</h3>
Market downturns don't just create challenges, they forge legends. History proves that when the economy stumbles, innovation surges. Some of the world's most successful companies weren't just built during crises; they were born because of them.
While most people saw chaos, these visionaries saw opportunity. They understood that innovation doesn't stop in downturns, it accelerates:
<ul>
<li>1893 – General Electric: While the Panic of 1893 crushed businesses nationwide, Thomas Edison's relentless drive led to the formation of GE. More than a century later, his vision still powers the world.</li>
</ul>
<ul>
<li>1908 – General Motors: While the Panic of 1907 triggered a 50% stock market decline, William Durant saw an opening and created GM, redefining the automobile industry.</li>
</ul>
<ul>
<li>1929 – Walt Disney Productions: Just as the Great Depression began, two brothers introduced the world to Mickey Mouse. From hardship, an entertainment empire was born.</li>
</ul>
<ul>
<li>1971 – Federal Express: As a recession ended and businesses doubted the reliability of overnight delivery, Fred Smith pressed forward, launching FedEx and reshaping global logistics.</li>
</ul>
<ul>
<li>1975 – Microsoft: With the stock market still reeling from a bear market and an oil crisis, two young programmers bet on the future of personal computing. Today, the company is worth trillions.</li>
</ul>
<ul>
<li>2008 – The Great Recession's Entrepreneurs: While Wall Street crumbled, the seeds of innovation were planted. Uber, Venmo, Square, and Instagram all emerged, transforming the way we live and transact.</li>
</ul>
<ul>
<li>2020 – A Pandemic and a Startup Boom: The fastest market decline in decades sent shockwaves through the world but entrepreneurs stepped forward, launching businesses at record levels. Some of today's most promising companies were born or reinvented in the uncertainty of a global crisis. One standout is Wiz, a cybersecurity startup founded in 2020, which just made history by securing a remarkable $32 billion acquisition by Google.</li>
</ul>
<h3 class="wp-block-heading">From fear to fortune: A simple framework</h3>
Market downturns test your resolve, but <a href="https://cosmodestefano.substack.com/p/10-habits-for-a-richer-happier-life">a disciplined approach</a> turns uncertainty into opportunity:
<ul>
<li>Plan: Define your long-term strategy based on your goals, risk tolerance, and timeline.</li>
<li>Course-Correct: Adjust as needed—not out of fear, but in response to life changes and financial milestones.</li>
<li>Repeat: Keep investing, trust the process, and let compounding do its work in up and down markets.</li>
</ul>
<h3 class="wp-block-heading">Look fear in the face</h3>
Down markets don't ask if you're ready; they test your mettle. Those who stay invested aren't just survivors; they're the biggest winners. You just won't recognize that fact until after the market rebounds.
<a href="https://cosmodestefano.substack.com/p/winning-the-long-game-investing-requires">Patience and discipline</a> are key virtues when it comes to long-term investing. And like the entrepreneurs that came before us, you also must learn to look fear in the face and not flinch.
Every bear market plants the seeds of the next bull market. But only those who stay invested will reap the rewards.
<h3 class="wp-block-heading">Sideline spectator or wealth creator?</h3>
Market downturns don't just destroy wealth, they create it. Long-term investors who maintain discipline during turbulent times consistently outperform those who panic and sell.
Compounding portfolio growth rewards patience. The market rewards courage, not capitulation.
As inevitable market downturns unfold, will fear keep you on the sidelines, or are you ready to seize the opportunity?
As always, invest often and wisely. Thank you for reading.
My book, <a href="https://geni.us/wealthyourwaypb" target="_blank" rel="noreferrer noopener">Wealth Your Way&nbsp;is available on Amazon</a>, and consider subscribing to <a href="https://cosmodestefano.substack.com/">my free newsletter</a>.
The content is for informational purposes only. It is not intended to be, nor should it be construed as legal, tax, investment, financial, or other advice. It is merely my own random thoughts.
<figure class="wp-block-image size-full is-resized"><a href="https://geni.us/wealthyourwaypb"><img loading="lazy" decoding="async" width="472" height="538" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31105237/WYW-with-2025-IPA-winner-and-store-logos.jpg" alt="" class="wp-image-9279" style="width:342px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31105237/WYW-with-2025-IPA-winner-and-store-logos.jpg 472w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/31105237/WYW-with-2025-IPA-winner-and-store-logos-263x300.jpg 263w" sizes="(max-width: 472px) 100vw, 472px" /></a></figure>
The best way to spread the word about a book you enjoyed is to leave an honest review. Thank you for taking the time to&nbsp;<a href="https://www.amazon.com/review/create-review/?ie=UTF8&amp;channel=glance-detail&amp;asin=B09XP7383J">click here</a>&nbsp;and post your review of&nbsp;Wealth Your Way. Your review will help other readers explore their own path to financial freedom!

Broad U.S. Equity ETFs

Opinion

Personal Finance

General

The Surprising Upside of a Market Meltdown

XHLD

TEN Holdings shares are trading lower after the company reported a year-over-year decrease in FY24 financial results.

Jefferies analyst Brent Thill maintains Workday (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) with a Buy and lowers the price target from $350 to $325.

WDAY

Jefferies Maintains Buy on Workday, Lowers Price Target to $325

TRAW

Traws Pharma FY24 EPS ($18.90) Up From ($22.57) YoY; Revenue $226K Inline YoY.

PRPH

ProPhase Labs shares are trading lower after the compant reported worse-than-expected FY24 financial results.

Jefferies analyst Brent Thill maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Buy and lowers the price target from $135 to $125.

ESTC

Jefferies Maintains Buy on Elastic, Lowers Price Target to $125

PGNY

Progyny Expands Maternal Health Support; Adds Doula Services

Press Releases

Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update

CEO Letter to Shareholders Issued by Tivic Health

Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma

Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team

Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve

Tivic Health Systems, Inc. Announces Reverse Stock Split

Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System

Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast

Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth

STAB

Autonomix Medical

Aspira Women's Health Inc. - Common Stock

Aspira Womens Health

Bluejay Diagnostics

GlucoTrack

HeartSciences

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

Know Labs

LogicMark

NanoVibronix

ENDRA Life Sciences

Nuwellis

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

SINTX Technologies

Venus Concept

Catheter Precision

월요일(24일) 아침 미국 지수 선물이 상승하고 있는 가운데, 오늘 투자자들의 주목을 받을 수 있는 주식들은 다음과 같다.
<ul>
<li>KB 홈 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>): 월요일 폐장 후 실적을 발표할 예정이며, 주당순이익 1.58달러, 매출 15억 달러로 예상된다. 주식은 금요일 애프터마켓에서 0.4% 상승한 60.00달러에 거래되었다.</li>
<li>티빅 헬스 시스템즈 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>): 2024년 12월 31일 종료된 연도에 570만 달러의 순손실을 기록했으며, 이는 전년의 820만 달러 손실보다 개선된 수치였다. 매출(반품 제외)은 80만 달러에서 120만 달러로 감소했다. 주식은 금요일 애프터마켓에서 6.1% 하락한 3.3341달러에 거래되었다.</li>
<li>인튜이티브 머신스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>): 월요일 개장 전 실적을 발표할 예정이며, 주당순손실 9센트, 매출 557만 달러로 예상된다. 주식은 금요일 애프터마켓에서 0.8% 상승한 7.15달러에 거래되었다.</li>
</ul>
자세한 내용은 <a href="https://www.benzinga.com/premarket/" target="_blank" rel="noopener">프리마켓 보도</a>를 확인하세요.
<ul>
<li>캐스터 마리타임 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRM#NASDAQ">CTRM</a>): M/V 매직 이클립스(Magic Eclipse)와 M/V 매직 칼리스토(Magic Callisto)를 2,800만 달러에 매각한다고 공시했다. 주식은 금요일 애프터마켓에서 0.4% 하락한 2.55달러에 거래되었다.</li>
<li>에너팩 툴 그룹 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAC#NYSE">EPAC</a>): 월요일 폐장 후 실적을 발표할 예정이며, 주당순이익 40센트, 매출 1억 4,160만 달러가 예상된다. 주식은 금요일 애프터마켓에서 0.1% 상승한 42.30달러에 거래되었다.</li>
</ul>
사진 출처: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Tivic Health Systems

뉴스

에 대한 최신 뉴스 Tivic Health Systems (NASDAQ:TIVC) 주식

월요일, 3월 24, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌